Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31true2Company was dormant22023-04-01falsetruefalse 02224208 2023-04-01 2024-03-31 02224208 2022-04-01 2023-03-31 02224208 2024-03-31 02224208 2023-03-31 02224208 c:Director2 2023-04-01 2024-03-31 02224208 d:ShareCapital 2024-03-31 02224208 d:ShareCapital 2023-03-31 02224208 d:RetainedEarningsAccumulatedLosses 2024-03-31 02224208 d:RetainedEarningsAccumulatedLosses 2023-03-31 02224208 c:OrdinaryShareClass1 2023-04-01 2024-03-31 02224208 c:OrdinaryShareClass1 2024-03-31 02224208 c:OrdinaryShareClass1 2023-03-31 02224208 c:EntityHasNeverTraded 2023-04-01 2024-03-31 02224208 c:FRS102 2023-04-01 2024-03-31 02224208 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 02224208 c:FullAccounts 2023-04-01 2024-03-31 02224208 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 02224208 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02224208









PRIORCLAVE SCIENTIFIC LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
PRIORCLAVE SCIENTIFIC LIMITED
REGISTERED NUMBER: 02224208

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
£
£

  

  

Total assets less current liabilities
  
 
-
 
-

  

Net assets
  
-
-


Capital and reserves
  

Called up share capital 
 4 
2,000
2,000

Profit and loss account
  
(2,000)
(2,000)

  
-
-


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by 




C A Prior Esq
Director

Date: 22 October 2024

The notes on page 2 form part of these financial statements.
Page 1

 
PRIORCLAVE SCIENTIFIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Priorclave Scientific Limited is a private company limited by shares and incorporated in England and Wales. The address of the registered office is 129 Nathan Way, West Thamesmead Business Park, London, SE28 0AB. The company was dormant in the period under review.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



2,000 (2023 - 2,000) Ordinary shares shares of £1.00 each
2,000
2,000


Page 2